letrozole

Italy

Drugs containing this active substance

  • BLORMAT

    It is used for the treatment of breast cancer in postmenopausal women. It is used to prevent the recurrence of the tumor, can be used as a first-line treatment before surgery or after surgery (or after five years of treatment with tamoxifen), and helps prevent the spread of the tumor in patients with advanced stage disease.

    Form: tablets, film-coated

    Active substance Dosage
    letrozole -

    ATC: L02BG04

    Manufacturer: FARMA GROUP S.R.L.

  • BRESTORAL

    It is used for the treatment of breast cancer in postmenopausal women. It is used to prevent recurrence, can be used as a first-line treatment before surgery (if immediate surgery is not possible), or after surgery or after five years of treatment with tamoxifen. It is also used to prevent the spread of cancer in patients with advanced breast cancer.

    Form: tablets, film-coated

    Active substance Dosage
    letrozole -

    ATC: L02BG04

    Manufacturer: WAVE PHARMA S.R.L.

  • FEMARA

    Femara is a hormonal treatment used for the treatment of breast cancer in postmenopausal women. It is used to prevent the recurrence of cancer, as initial treatment before surgery (if surgery cannot be performed immediately), or after surgery or after five years of treatment with tamoxifen. It is also used to prevent the spread of cancer to other parts of the body in patients with advanced stage disease.

    Form: tablets, film-coated

    Active substance Dosage
    letrozole -

    ATC: L02BG04

    Manufacturer: NOVARTIS FARMA S.P.A.

  • FEMELIX

    It is used for the treatment of breast cancer in postmenopausal women. It is used to prevent the recurrence of the tumor and can be used as a first-line treatment before or after surgery, or to prevent the spread of the tumor in cases of advanced cancer.

    Form: tablets, film-coated

    Active substance Dosage
    letrozole -

    ATC: L02BG04

    Manufacturer: ELLEVA PHARMA SRL

  • GOSURAN

    Gosuran is used for the treatment of breast cancer in postmenopausal women. It is used to prevent the recurrence of cancer, can be used as a first-line treatment before surgery or after surgery, or after five years of treatment with tamoxifen, and can prevent the spread of cancer in patients with advanced stage disease.

    Form: tablets, film-coated

    Active substance Dosage
    letrozole -

    ATC: L02BG04

    Manufacturer: GENETIC S.P.A.

  • LETRIX

    It is used for the treatment of breast cancer in postmenopausal women. It is used to prevent the recurrence of cancer, can be used as a first-line treatment before surgery (if immediate surgery is not possible), or after surgery or after five years of treatment with tamoxifen. It is also used to prevent the spread of cancer in patients with advanced stage disease.

    Form: tablets, film-coated

    Active substance Dosage
    letrozole -

    ATC: L02BG04

    Manufacturer: SOPHOS BIOTECH S.R.L.

  • LETROZOLE ALMUS

    It is used for the treatment of breast cancer in women in menopause. It is used to prevent the cancer from recurring, can be used as a first treatment before surgery (if surgery cannot be performed immediately) or after surgery or after five years of treatment with tamoxifen. It is also used to prevent the spread of cancer to other parts of the body in patients with advanced stage cancer.

    Form: tablets, film-coated

    Active substance Dosage
    letrozole -

    ATC: L02BG04

    Manufacturer: ALMUS S.R.L.

  • LETROZOLE AUROBINDO ITALIA

    It is used for the treatment of breast cancer in women in menopause. It is used to prevent the cancer from recurring, can be used as a first treatment before surgery (if surgery cannot be performed immediately), or after surgery or after five years of treatment with tamoxifen. It is also indicated to prevent the spread of cancer to other parts of the body in patients with advanced stage disease.

    Form: tablets, film-coated

    Active substance Dosage
    letrozole -

    ATC: L02BG04

    Manufacturer: Eugia Pharma (Malta) Limited

  • LETROZOLE DOC GENERICI

    It is used for the treatment of breast cancer in postmenopausal women. It is also used to prevent the recurrence of cancer, as a first-line treatment before or after surgery, or to prevent the spread of cancer in advanced stage cases.

    Form: tablets, film-coated

    Active substance Dosage
    letrozole -

    ATC: L02BG04

    Manufacturer: DOC GENERICI SRL

  • LETROZOLE EG

    It is used for the treatment of breast cancer in women in menopause. It is used to prevent the recurrence of cancer, can be used as a first-line treatment before surgery or after five years of treatment with tamoxifen, and helps to prevent the spread of cancer in advanced stages.

    Form: tablets, film-coated

    Active substance Dosage
    letrozole -

    ATC: L02BG04

    Manufacturer: EG S.P.A.

  • LETROZOLE MYLAN GENERICS

    It is used for the treatment of breast cancer in women in menopause. It is used to prevent the recurrence of cancer, can be used as a first-line treatment before surgery (if immediate surgery is not possible), or after surgery or after five years of treatment with tamoxifen. It is also used to prevent the spread of cancer to other parts of the body in patients with advanced-stage cancer.

    Form: tablets, film-coated

    Active substance Dosage
    letrozole -

    ATC: L02BG04

    Manufacturer: MYLAN S.P.A.

  • LETROZOLE PENSA

    It is used for the treatment of breast cancer in women in menopause. It is used to prevent the recurrence of cancer, can be used as a first treatment before surgery or after surgery (or after five years of tamoxifen), and helps prevent the spread of cancer in patients with advanced stage.

    Form: tablets, film-coated

    Active substance Dosage
    letrozole -

    ATC: L02BG04

    Manufacturer: TOWA PHARMACEUTICAL S.P.A.

  • LETROZOLE SANDOZ

    It is used for the treatment of breast cancer in women in menopause. It is used to prevent the recurrence of cancer, as a first-line treatment before surgery (if surgery cannot be performed immediately), or after surgery or after five years of treatment with tamoxifen. It is also used to prevent the spread of cancer in patients with advanced stage disease.

    Form: tablets, film-coated

    Active substance Dosage
    letrozole -

    ATC: L02BG04

    Manufacturer: SANDOZ S.P.A.

  • LETROZOLE SUN

    It is used for the treatment of breast cancer in women in menopause. It is used to prevent the cancer from recurring, can be used as a first-line treatment before surgery (if surgery cannot be performed immediately), or after surgery or after five years of treatment with tamoxifen. It is also used to prevent the spread of cancer to other parts of the body in patients with advanced stage disease.

    Form: tablets, film-coated

    Active substance Dosage
    letrozole -

    ATC: L02BG04

    Manufacturer: SUN PHARMACEUTICAL INDUSTRIES (EUROPE) B.V.

  • LETROZOLE TECNIGEN

    It is used for the treatment of breast cancer in postmenopausal women. It is also used to prevent the recurrence of cancer, as a first-line treatment before or after surgery, or to prevent the spread of cancer in an advanced stage.

    Form: tablets, film-coated

    Active substance Dosage
    letrozole -

    ATC: L02BG04

    Manufacturer: TECNIMEDE - SOCIEDADE TECNICO-MEDICINAL, SA

  • LETROZOLE TEVA

    It is used for the treatment of breast cancer in postmenopausal women. It is also used to prevent the recurrence of cancer, as a first-line treatment before or after surgery, or to prevent the spread of cancer in patients with advanced stage disease.

    Form: tablets, film-coated

    Active substance Dosage
    letrozole -

    ATC: L02BG04

    Manufacturer: TEVA ITALIA S.R.L.

  • LETROZOLE ZENTIVA

    It is used for the treatment of breast cancer in women in menopause. It is used to treat the tumor, prevent its recurrence, or as a first-line treatment before or after surgery. It is also used to prevent the spread of the tumor in patients with advanced stage disease.

    Form: tablets, film-coated

    Active substance Dosage
    letrozole -

    ATC: L02BG04

    Manufacturer: ZENTIVA ITALIA S.R.L.

  • RAMATES

    It is used for the treatment of breast cancer in postmenopausal women. It is used to prevent the recurrence of cancer and can be used as a first-line treatment before or after surgery, or to prevent the spread of cancer in advanced stage cases.

    Form: tablets, film-coated

    Active substance Dosage
    letrozole -

    ATC: L02BG04

    Manufacturer: JUST PHARMA S.R.L.

  • RAZIOLET

    It is used for the treatment of breast cancer in postmenopausal women. It is also used to prevent the recurrence of cancer, as initial treatment before surgery (if surgery cannot be performed immediately), or after surgery or after five years of treatment with tamoxifen. Additionally, it helps to prevent the spread of cancer to other parts of the body in patients with advanced-stage cancer.

    Form: tablets, film-coated

    Active substance Dosage
    letrozole -

    ATC: L02BG04

    Manufacturer: ELLEVA PHARMA SRL

  • ZOLOBREST

    It is used for the treatment of breast cancer in postmenopausal women. It is used to prevent the cancer from returning, can be used as a first-line treatment before surgery (if immediate surgery is not possible), or after surgery or after five years of treatment with tamoxifen. It is also used to prevent the spread of cancer in patients with advanced stage disease.

    Form: tablets, film-coated

    Active substance Dosage
    letrozole -

    ATC: L02BG04

    Manufacturer: ACCORD HEALTHCARE, S.L.U.

  • ZOLTRON

    Zoltron is used for the treatment of breast cancer in postmenopausal women. It is used to prevent the recurrence of cancer after surgery or after treatment with tamoxifen, or to prevent the spread of cancer in patients with advanced stage disease.

    Form: tablets, film-coated

    Active substance Dosage
    letrozole -

    ATC: L02BG04

    Manufacturer: ISTITUTO GENTILI S.R.L.